PI
HZNP

PGGM Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

PGGM Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,989
Closed -$1.16M – 367
2023
Q3 		$1.16M Buy
+9,989
New +$1.07M 0.02% 296
2022
Q1 		$175K Hold
1,625
– – ﹤0.01% 363
2021
Q4 		$175K Buy
+1,625
New +$177K ﹤0.01% 363

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PGGM Investments's HZNP Position: Q4 2023 in Review

PGGM Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 9,989 shares — an estimated $1.16M sold.

PGGM Investments first reported a position in HZNP in Q4 2021 and held it in 3 quarters. The position peaked at $1.16M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • PGGM Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • PGGM Investments sold 9,989 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.16M.
  • PGGM Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 3 quarters.
  • PGGM Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.16M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on PGGM Investments's 13F filing for Q4 2023, filed 5 Feb 2024.